While there was no significant correlation between endogenous ezrin levels and chemotherapeutic sensitivity across this panel of breast cancer cells (Supplementary Fig. S1B), experimental manipulation of ezrin expression in selected cell lines was associated with significant alterations in response to chemotherapy drug treatment. The gene discussed is EZR; the disease is breast carcinoma.